Sign in

You're signed outSign in or to get full access.

PI

PYXUS INTERNATIONAL, INC. (PYYX)·Q4 2025 Earnings Summary

Executive Summary

  • Q4 revenue rose 25.0% year over year to $501.7M; net loss narrowed to $(5.1)M and diluted EPS was $(0.20). Gross profit reached $67.2M and operating income was $13.7M .
  • FY 2025 delivered 22.1% revenue growth to $2.48B, adjusted EBITDA increased 7.5% to $208.4M, and leverage fell to 3.70x (lowest in 10+ years), driven by stronger gross profit, accelerated operating cycle, and debt reduction .
  • FY 2026 initial guidance: sales $2.3B–$2.5B and adjusted EBITDA $205M–$235M, with sales weighted to 2H; later updated to sales $2.4B–$2.6B and adjusted EBITDA $215M–$235M, tightening the lower bound as visibility improved .
  • Stock reaction catalysts: expanded FY26 guidance range and margin narrative (higher volumes, lower selling prices, improved gross margins), improved leverage/credit metrics, and ABL facility upsizing with lower rates and extended term supporting liquidity .

What Went Well and What Went Wrong

What Went Well

  • Strong FY 2025 execution despite El Niño: “we leveraged our global footprint to increase volume and overcome El Niño-driven undersupply conditions…deliver significant revenue, gross profit, operating income and net income growth” .
  • Working capital discipline: operating cycle accelerated by 38 days; FY adjusted free cash flow of $151.9M; net debt down to $771.6M; leverage to 3.70x; interest coverage to 1.57x .
  • Q4 operational performance: revenue up 25% YoY to $501.7M; gross profit $67.2M; operating income $13.7M; net interest expense improved to $26M vs. $30M prior-year, aided by debt reduction and shipment timing .

What Went Wrong

  • Weather-driven margin pressure: El Niño reduced South American volumes and impacted quality/margins; Q4 gross margin lower vs. peak quarters and FY gross profit as % of sales down year over year in some periods .
  • Interest cost remains heavy: FY interest expense $128.0M; quarterly net interest expense remained sizable despite sequential improvement .
  • Q4 bottom line loss: Q4 net loss of $(5.1)M and diluted EPS $(0.20), reflecting seasonality and expense mix; continued reliance on non-GAAP to frame operating performance (Adjusted EBITDA, Adjusted FCF) .

Financial Results

MetricQ4 2024Q3 2025Q4 2025
Revenue ($USD Millions)$401.4 $778.3 $501.7
Diluted EPS ($USD)$(0.40) $0.74 $(0.20)
Gross Profit ($USD Millions)$58.0 $116.4 $67.2
Operating Income ($USD Millions)$8.1 $66.1 $13.7
Gross Profit Margin %14.44%*14.96%*13.40%*
EBIT Margin %2.02%*8.50%*2.19%*

Values with an asterisk were retrieved from S&P Global.

Segment breakdown (FY 2025):

SegmentFY 2025FY 2024Change ($)Change (%)
Leaf Product Revenue ($USD Millions)$2,335.1 $1,912.4 $422.7 22.1%
Leaf Kilos Sold (Millions)383.4 370.7 12.7 3.4%
Avg Price per Kilo ($USD)$6.09 $5.16 $0.93 18.0%
Avg Gross Profit per Kilo ($USD)$0.84 $0.78 $0.06 7.7%
Processing & Other Revenues ($USD Millions)$135.9 $117.2 $18.7 16.0%

KPIs:

KPIQ4 2025FY 2025
EBITDA ($USD Millions)$20.38 $193.66
Adjusted EBITDA ($USD Millions)$28.61 $208.41
Adjusted Free Cash Flow ($USD Millions)$195.88 $151.90
Net Debt ($USD Millions)—$771.64
Net Debt / Adjusted EBITDA (x)—3.70x
Uncommitted Inventory ($USD Millions)$7.6 (≈1% total inv.) $7.6

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
SalesFY 2025$2.15B–$2.35B (Nov-2024) $2.40B–$2.55B (Feb-2025) Raised
Adjusted EBITDAFY 2025$175M–$195M (Nov-2024) $205M–$215M (Feb-2025) Raised
SalesFY 2026$2.30B–$2.50B (Jun-2025) $2.40B–$2.60B (Nov-2025) Raised
Adjusted EBITDAFY 2026$205M–$235M (Jun-2025) $215M–$235M (Nov-2025) Tightened higher lower bound

Earnings Call Themes & Trends

TopicPrevious Mentions (Q2 2025 & Q3 2025)Current Period (Q4 2025)Trend
Weather/El Niño impactManaged margin pressure; shifted mix to Africa/Asia; accelerated shipments Expect larger crops at reduced cost in South America/Africa; replenish inventory Improving supply; margin tailwinds
Working capital and leveragePeak seasonal debt and inventories; plan improvement as inventory converts to revenue Operating cycle accelerated; leverage down to 3.70x; continued focus on credit profile Balance sheet strengthening
Tariffs/macroAcknowledged trade policy risks FY26 guidance reflects tariff scenario variability Risk monitored; embedded in outlook
Processing/third-party servicesQ3: processing gross profit pressured by lower Zimbabwe volumes Expect increased third-party processing with larger crops; margin expansion Recovering volumes; margin support
Sustainability/ESGSustainability report; 16% Scope 3 reduction since FY21 SBTi validation of near-term targets Strategic alignment with customers
Next-gen products (IQOS supply chain)—Company “heavily involved” in U.S. heat-not-burn supply chain; positive business stream Optionality; customer-linked growth

Management Commentary

  • CEO: “Fiscal 2025 was an exemplary year…we leveraged our global footprint to increase volume and overcome El Niño-driven undersupply…deliver significant revenue, gross profit, operating income and net income growth” .
  • CFO (Interim): “We retired $65M of senior debt in FY25…$143M since 03/01/2024…reduced leverage from 4.8x to 3.7x…the lowest it’s been in over ten years” .
  • CEO on FY26 margins: “Volumes will increase, gross margins will increase…reflective of increased volumes, lower selling prices, and higher margins” .
  • CEO on inventory: “As of 03/31/2025, we have only $8M of uncommitted inventory (~1%)…total inventory $762M vs. $932M last year” .

Q&A Highlights

  • 2H weighting: Sales and EBITDA expected to be 2H-weighted as larger crops are purchased/processed/shipped; inventory replenishment drives timing .
  • Margin drivers FY26: Lower selling prices on larger crops with better quality; higher volumes and gross margin expansion anticipated, particularly in South America .
  • Free cash flow outlook: Focus on being cash generative before working capital changes; normalized Brazilian purchasing cadence expected to help cash flow .
  • Capital structure: Management evaluating strategic options; no specific refinancing updates, but improvement in credit metrics positions future actions .
  • IQOS in U.S.: Pyxus “heavily involved” in supply chain; positive for business though commercialization timing not provided .

Estimates Context

  • Wall Street consensus estimates for PYYX quarterly EPS/revenue/target price were not available via S&P Global for the periods requested; only actuals for Q2 FY26 populate in the feed. As a result, comparisons versus consensus are not shown [GetEstimates]. Values with an asterisk in tables were retrieved from S&P Global.

Key Takeaways for Investors

  • Q4 capped a strong FY 2025 with 22% top-line growth and leverage down to 3.70x; the operating cycle acceleration and debt reduction materially improved credit profile .
  • Narrative shifts to FY26 margin expansion: larger crops, lower selling prices, better mix and processing volume should lift margins even if revenue moderates at the midpoint .
  • Guidance momentum is positive: FY26 sales raised to $2.4B–$2.6B and adjusted EBITDA tightened to $215M–$235M, signaling confidence in execution and mix .
  • Liquidity and cost of capital improving: ABL upsized to $150M with lower spreads and extended maturity; sequential net interest expense improvement evident in Q4 .
  • Watch tariff dynamics and shipping/logistics: management embeds tariff uncertainty in guidance; continued focus on operating cycle efficiency and 2H shipment cadence .
  • Optionality in next-gen tobacco supply chains (IQOS) and recovery in third-party processing volumes provide incremental medium-term margin support .
  • Near-term trading setup: stock likely reacts to guidance updates and margin commentary; monitor 2H execution on processing/shipping and any refinancing announcements to further derisk balance sheet .